Sekihara H, Yazaki Y
Third Department of Internal Medicine, University of Tokyo, Faculty of Medicine, Japan.
J Steroid Biochem Mol Biol. 1993 Jul;46(1):69-72. doi: 10.1016/0960-0760(93)90210-n.
The amplification of the action of aldosterone by 19-oxoandrost-4-ene-3,17-dione (19-oxo-A-dione) was evaluated by mineralocorticoid bioassays using adrenalectomized rats. Pretreatment of rats with 19-oxo-A-dione did not cause any significant change in urinary Na/K ratio. However, aldosterone caused a significantly lower urinary Na/K ratio and Na excretion in rats pretreated with 19-oxo-A-dione than in rats without pretreatment. These results indicate that the sodium-retaining action of aldosterone is amplified by pretreatment with 19-oxo-A-dione.
通过对肾上腺切除大鼠进行盐皮质激素生物测定,评估了19-氧代雄甾-4-烯-3,17-二酮(19-氧代-A-二酮)对醛固酮作用的增强效果。用19-氧代-A-二酮预处理大鼠,其尿钠/钾比值未发生任何显著变化。然而,与未预处理的大鼠相比,醛固酮使经19-氧代-A-二酮预处理的大鼠尿钠/钾比值和钠排泄量显著降低。这些结果表明,用19-氧代-A-二酮预处理可增强醛固酮的保钠作用。